Effects of a caregiver's physical contact on ICU patients
Official title: Physiological Changes in Adult Intensive Care Patients Upon Contact With Their Primary Caregiver (CARE-ICU): A Randomized Clinical Trial
Run by Universidad Autonoma del Estado de Mexico · NCT07761364 · Data updated 2026-11-12
This study tests whether brief physical contact from a patient’s primary caregiver can influence vital signs in adults in intensive care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 59 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Universidad Autonoma del Estado de Mexico Academic / other |
| Locations | 1 site (Mexico City, Mexico City) |
| Status | Recruiting |
| Started | August 1, 2026 |
| Main results expected | August 31, 2026 |
| Study ends | August 31, 2026 |
| Registry record updated | August 12, 2026 |
| Trial ID | NCT07761364 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older in the ICU for 24–48 hours with stable sedation (RASS -3 to -1 or 0 to +3) and a GCS > 13, with an identified primary caregiver who can participate and consent.
✕Probably not a fit
Patients with neurological disorders, MODS, unstable arrhythmias, fever, or hypertension at assessment may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, parallel-group trial compares standardized therapeutic physical contact from the patient’s primary caregiver to a control condition with no such contact in adult ICU patients. Participants are randomly assigned in a 1:1 ratio with allocation concealment, and outcomes are measured at three time points around the caregiver visit using bedside monitoring. The study focuses on physiological parameters such as heart rate, blood pressure, respiratory rate, oxygen saturation, and temperature to see if caregiver interaction affects these measures. Eligible patients are adults in the ICU for 24–48 hours with specific sedation and consciousness criteria, and their identified primary caregiver must participate under informed consent. The trial is conducted at the Instituto Nacional de Enfermedades Respiratorias with the Universidad Autonoma del Estado de Mexico as lead sponsor.
Why it matters
Potential benefit: If successful, patients may experience improved physiological stability during caregiver interactions in the ICU.
How similar studies have gone: Prior studies on caregiver involvement in critical care have shown mixed results; this trial tests a specific, standardized contact intervention in a rigorous RCT design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria Patient Criteria: * Adults aged 18 years or older. * Admission to the intensive care unit (ICU) for 24 to 48 hours. * Richmond Agitation-Sedation Scale (RASS) score between -3 and -1 or between 0 and +3. * Glasgow Coma Scale score greater than 13. Primary Caregiver Criteria: * Identified as the patient's primary caregiver. * Willing and able to participate in the study. * Provides written informed consent prior to study participation. Exclusion Criteria Patient Criteria: * Diagnosis of a neurological disorder (e.g., cerebrovascular disease or stroke). * Multiple organ dysfunction syndrome (MODS). * Unstable or difficult-to-control cardiac arrhythmias. * Fever (body temperature ≥ 37.5°C) at the time of assessment. * Hypertension (blood pressure ≥ 130/80 mmHg) at the time of assessment. Primary Caregiver Criteria: \- Unable to be present to perform the intervention according to the study protocol.
Where it's running
-
Investigación del Instituto Nacional de Enfermedades Respiratorias
Mexico City, Mexico City, Mexico Recruiting
Study contacts
- Principal investigator: Isabel Álvarez-Solorza, RN, PhD — Universidad Autonoma del Estado de Mexico
- Study coordinator: Isabel Álvarez-Solorza, Dr.
- Email: ialvarezs@uaemex.mx
- Phone: +52 1 7222231161
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
-
Cycling with immersive VR for ICU patients recovering from critical illness
In this crossover study, critically ill adults in the ICU will try three 10-minute cycling sessions to see if an immersive VR environment motivates them more than cycling with no visuals or cycling while watching a route on a TV.
-
Factors Influencing Outcomes in ECMO and Impella Patients
This study tests whether metabolic and thyroid hormone changes help predict survival for adults on ECMO or Impella at a single Hungarian cardiac ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.